Skip and its mate (an offshore PE fund) are expected to offer a 70 per cent premium to take Genex Power off the ASX boards, which is the sort of premium that would normally encourage a company to at least engage.
Genex Power has Goldman Sachs in its corner; it saw Friday night’s trade, where Skip and Co raided the renewables group’s register at a premium, and knew there was a bid incoming.
Sydney-based portable defibrillator maker Rapid Response Revival (RRR) is heading overseas as it eyes US$100 million of fresh funds to scale up to 1.5 million units annually by the 2025 financial year.